Hepatitis C reinfection in patients with sustained virologic response at a national hospital in Peru, 2024

Rommel Zambrano-Huailla; Omar Rodríguez Lozano; César Castro Villalobos; Jorge Garavito-Rentería; César Cabezas Sánchez

doi:10.17843/rpmesp.2025.422.14428

Authors

Rommel Zambrano-Huailla Unidad de Hígado, Servicio de Gastroenterología, Hospital Nacional Arzobispo Loayza, Lima, Perú https://orcid.org/0000-0002-3711-7945
Omar Rodríguez Lozano Unidad de Hígado, Servicio de Gastroenterología, Hospital Nacional Arzobispo Loayza, Lima, Perú https://orcid.org/0009-0005-1424-852X
César Castro Villalobos Unidad de Hígado, Servicio de Gastroenterología, Hospital Nacional Arzobispo Loayza, Lima, Perú https://orcid.org/0000-0001-9377-6200
Jorge Garavito-Rentería Unidad de Hígado, Servicio de Gastroenterología, Hospital Nacional Arzobispo Loayza, Lima, Perú https://orcid.org/0000-0002-5482-596X
César Cabezas-Sánchez Instituto Nacional de Salud, Lima, Perú https://orcid.org/0000-0001-5120-0713

DOI:

https://doi.org/10.17843/rpmesp.2025.422.14428

Downloads

Download data is not yet available.

References

Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJF, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol [Internet]. 2022;7(8):724–35. doi: 10.1016/S2468-1253(22)00050-4.

World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022. p.

–363.

Guidance Panel AASLD-IDSA Hepatitis C. Hepatitis C guidance 2019 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology. 2020;71(2):686–721. doi: 10.1002/hep.31060.

Reiberger T, Lens S, Cabibbo G, Nahon P, Zignego AL, Deterding K, et al. EASL position paper on clinical follow-up after HCV cure. J Hepatol. 2024;81(2):326–44. doi: 10.1016/j.jhep.2024.04.007.

Vergara-Samur H, Martínez-Vernaza S, De la Hoz A, Barahona-Correa J, Ortiz JP, Gualtero-Trujillo S, et al. Comparative outcomes of direct-acting antiviral treatment in patients with HIV-Hepatitis C co-infection: insights from a single center experience in Colombia. Infez Med. 2023;31(3):374–83. doi: 10.53854/liim-3103-11.

Collins JA, Chamorro ER, Castillo RA. Éxito de los antivirales de acción Directa para hepatitis C en pacientes VIH-positivos de un hospital terciario, Lima, Perú. Rev Soc Peru Med Interna. 2024;37(1):21–4.